John Nicholson, SVP & Chief Operating Officer at NEKTAR THERAPEUTICS (NKTR), sold 6,354 shares at $19.32 ($123K) on 2017-08-16, disclosed to the SEC on 2017-08-18.
Open-market sale of $123k NKTR by SVP & Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.32 | 3,177 | $61K | 50.0% |
| 2 | $19.32 | 3,177 | $61K | 50.0% |
| Total | $19.32 avg | 6,354 | $123K | 100% |
| Filing → |
| NKTR | SELL | 2019-02-21 | $324K | — | Filing → |
| NKTR | SELL | 2019-01-30 | $2.7M | — | Filing → |
| NKTR | SELL | 2018-11-19 | $458K | — | Filing → |